News | September 26, 2022
NATCO launches Chlorantraniliprole (CTPR) formulated product NATGEN
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
Sud has more than 32 years of work experience with different companies like Clivient, Jubilant Life Sciences, Piramal Enterprises, Parabolic Drugs, Orchid Chemicals and Pharmaceuticals, Ranbaxy Labs, and Lupin
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
One in two women with advanced ovarian cancer has an HRD-positive tumor
The ANDA was filed as 'First to File' submission on NCE-1 date.
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Subscribe To Our Newsletter & Stay Updated
